发明名称 5'-CARBAMOYL-1,1'-BIPHENYL-4-CARBOXAMIDE DERIVATIVES AND THEIR USE AS P38 KINASE INHIBITORS
摘要 Compounds of formula (I): wherein X is a bond or a phenyl group which may be optionally substituted; R<sp>1</sp> is selected from an optionally substituted five− to seven−membered heterocyclic ring, an optionally substituted five− to seven−membered heteroaryl ring and an optionally substituted fused bicyclic ring; R<sp>2</sp> is selected from hydrogen, C<sb>1−6</sb><sp> </sp>alkyl and −(CH<sb>2</sb>)<sb>p</sb>−C<sb>3−7</sb>cyc loalkyl; or when X is a bond and m and n are both zero R<sp>1</sp> and R<sp>2</sp>, together with the nitrogen atom to which they are bound, form a five− to six−membered heterocyclic ring optionally containing one additional heteroatom selected from oxygen and nitrogen, which can be optionally substituted by C<sb>1−4</sb>alkyl; R<sp>3</sp> is the group −CO−NH−(CH<sb>2</sb>)<sb>q</sb>−R<sp >4</sp>; U is selected from methyl and halogen; W is selected from methyl and chlorine; V and Y are each selected independently from hydrogen, methyl and halogen; Z is selected from −O− and a bond; m and n are independently selected from 0, 1 and 2, wherein each carbon atom of the resulting carbon chain may be optionally substituted with up to two groups selected independently from C<sb>1−6</sb>alkyl, and the sum of m+ n is from 0 to 4; p is selected from 0 and 1; q and s are selected from 0, 1 and 2; r is selected from 0, 1 and 2; or pharmaceutically acceptable salts or solvated thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
申请公布号 WO03032980(A1) 申请公布日期 2003.04.24
申请号 WO2002EP11573 申请日期 2002.10.16
申请人 GLAXO GROUP LIMITED;ANGELL, RICHARD, MARTYN;ASTON, NICOLA, MARY;BAMBOROUGH, PAUL;BAMFORD, MARK, JAMES;COCKERILL, GEORGE, STUART;MERRICK, SUZANNE, JOY;WALKER, ANN, LOUISE 发明人 ANGELL, RICHARD, MARTYN;ASTON, NICOLA, MARY;BAMBOROUGH, PAUL;BAMFORD, MARK, JAMES;COCKERILL, GEORGE, STUART;MERRICK, SUZANNE, JOY;WALKER, ANN, LOUISE
分类号 C07D295/12;A61K31/341;A61K31/40;A61K31/417;A61K31/4174;A61K31/426;A61K31/435;A61K31/4409;A61K31/495;A61K31/5375;A61P1/04;A61P3/10;A61P7/00;A61P7/02;A61P9/00;A61P9/04;A61P9/10;A61P11/00;A61P11/06;A61P13/12;A61P17/00;A61P17/06;A61P19/02;A61P19/08;A61P19/10;A61P21/00;A61P25/00;A61P25/04;A61P25/08;A61P25/14;A61P25/16;A61P25/28;A61P27/14;A61P29/00;A61P31/04;A61P33/06;A61P35/00;A61P37/06;A61P37/08;A61P43/00;C07D211/26;C07D213/40;C07D233/61;C07D233/64;C07D277/28;C07D295/13;C07D295/135;C07D295/16;C07D295/182;C07D307/14;C07D307/52;C07D307/66;C07D521/00;(IPC1-7):A61K31/40;A61K31/440;A61K31/445;A61K31/446;A61K31/537;C07D295/18 主分类号 C07D295/12
代理机构 代理人
主权项
地址